u/EarlyPen7438

https://www.facebook.com/reel/1364188398867319

"Third time’s the charm for SpaceX CRS 34 — and tonight’s launch carries something extraordinary. 🚀

Aspera Biomedicines is sending its second investigation to the International Space Station to advance development of rebecsinib, a small molecule ADAR1 inhibitor recently approved by the U.S. Food and Drug Administration to begin first-in-human trials.

By studying their “kill‑switch” cell therapy in microgravity, researchers can observe cellular behavior in ways that are impossible on Earth.

Liftoff is targeted for tonight at 6:05 p.m. ET from Space Launch Complex 40 (SLC-40) at Cape Canaveral Space Force Station in Florida."